Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04586530 · ClinicalTrials.gov registry record · NA
Telehealth and Memory Study
A NA study of Chemotherapy-related Cognitive Dysfunction, sponsored by University of Pittsburgh.
- Active
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 2
- Study locations
NCT04586530 is a NA study of Chemotherapy-related Cognitive Dysfunction that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 220 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT04586530, a NA study of Chemotherapy-related Cognitive Dysfunction, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 2
- Study locations
Study Summary
The overall purpose of this trial is to confirm the efficacy of Memory and Attention Adaptation Training (MAAT), a cognitive-behavioral therapy (CBT) for treatment of chemotherapy-related cognitive dysfunction among (female or male) breast cancer survivors. This is a multi-center, multi-clinician randomized control trial (MAAT vs. supportive therapy attention control condition). This trial will also evaluate a sub-sample of survivors pre-and post treatment with functional magnetic resonance imaging (fMRI) in a working memory task to evaluate pre-to-post treatment brain activation patterns to elucidate underlying mechanisms of clinical therapeutic change.
Conditions Studied
Interventions
- BEHAVIORAL Supportive Therapy (ST)
- BEHAVIORAL Memory and Attention Adaptation Training (MAAT)
Study Locations (2)
Indiana
- Indiana University - Indianapolis
Pennsylvania
- UPMC Hillman Cancer Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2021-03-18 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04586530
The ClinicalTrials.gov registry entry for NCT04586530 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chemotherapy-related Cognitive Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Supportive Therapy (ST) is the first listed.
NCT04586530 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04586530 about?
NCT04586530 is a clinical study titled "Telehealth and Memory Study". The overall purpose of this trial is to confirm the efficacy of Memory and Attention Adaptation Training (MAAT), a cognitive-behavioral therapy (CBT) for treatment of chemotherapy-related cognitive dysfunction among (female or male) breast cancer survivors. This is a multi-center, multi-clinician ra...
What is the current status of trial NCT04586530?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2021-03-18. Estimated completion is 2026-07-31.
What conditions does trial NCT04586530 study?
This clinical trial studies the following conditions: Chemotherapy-related Cognitive Dysfunction.
What interventions are being tested in trial NCT04586530?
The interventions under investigation include: Supportive Therapy (ST) (BEHAVIORAL), Memory and Attention Adaptation Training (MAAT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04586530?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04586530 being conducted?
This trial has 2 study locations across Indiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.